+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

New Developments in Hodgkin's Lymphoma, An Issue of Hematology/Oncology Clinics of North America. The Clinics: Internal Medicine Volume 40-2

  • Book

  • March 2026
  • Region: North America
  • Elsevier Health Science
  • ID: 6252457
In this issue of Hematology/Oncology Clinics, guest editors Drs. Alex F. Herrera and Alison J. Moskowitz bring their considerable expertise to the topic of New Developments in Hodgkin's Lymphoma. Top experts focus on how advances in our understanding of Hodgkin’s lymphoma biology, diagnostics, and novel therapies have revolutionized the management of Hodgkin’s lymphoma.- Contains 13 relevant, practice-oriented topics including updates in our understanding of the biology of classic Hodgkin’s lymphoma; new standards in advanced stage Hodgkin’s lymphoma: selecting a novel regimen; adolescents and young adults with Hodgkin’s lymphoma; management of classic Hodgkin’s lymphoma in pregnancy; health disparities in classic Hodgkin’s lymphoma; and more- Provides in-depth clinical reviews on new developments in Hodgkin's lymphoma, offering actionable insights for clinical practice- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?
Early-Stage Hodgkin Lymphoma: Time for Novel Agents?
New Standards in Advanced-stage Hodgkin Lymphoma: Selecting a Novel Regimen
Classic Hodgkin Lymphoma in the Older Adult: What’s New?
Management of Classic Hodgkin Lymphoma in Pregnancy
New Developments in Hodgkin’s Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma
The Modern Role of Radiation Therapy in Classic Hodgkin Lymphoma
Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies
The Role of Stem Cell Transplantation in Hodgkin Lymphoma
Cellular and Novel Immunotherapies for Classic Hodgkin Lym

Authors

Alex F. Herrera Chief, Division of Lymphoma, Professor, Department of Hematology and Hematopoietic Cell Transplantation, Medical Director of the City of Hope Clinical Trials Office, Associate Medical Director of the Briskin Center for Clinical Research, City of Hope Medical Center, USA. Alison J. Moskowitz Hematologist-Oncologist, Memorial Sloan Kettering Cancer Center, New York, USA.